Momentum Stocks in Focus: Companhia Paranaense de Energia (ADR)(NYSE:ELP), The GEO Group Inc (NYSE:GEO), Sangamo Biosciences, Inc. (NASDAQ:SGMO)

On Friday, Shares of Companhia Paranaense de Energia (ADR)(NYSE:ELP), subtract -11.37% and closed at $8.42 in the last trading session. The last trading range of the stock ranges between $7.88 and $8.61.

Companhia Paranaense de Energia – Copel (NYSE: ELPVY, ELP / Latibex: XCOP / BM&FBovespa: CPLE3, CPLE5, CPLE6), a company that generates, transmits, distributes and sells power, declared its results for the third quarter of 2016.

Copel’s EBITDA came to R$427.7 million in 3Q16, 42.9% higher than the R$299.2 million recorded in 3Q15. This performance was positively influenced by: (a) Copel Distribuição’s result, because of the 4th Tariff Review Cycle, (b) Copel GeT’s strategy to allocate energy to the short-term market, and (c) the 17.0% growth in equity in earnings of auxiliaries the results of investees, because of the startup of new transmission assets. The result presented was partially offset by: (a) the negative impact of R$206.4 million referring to the cash flow remeasurement of assets related to RBSE, (b) the non-activation of the Araucária TPP, and (c) the 9% decline in captive market consumption, mainly because of the migration of customers to the free market.

The GEO Group Inc (NYSE:GEO), jumped 2.79% and closed at $30.60 in the last trading session. The last trading range of the stock ranges between $29.50 and $30.77. The company’s Market capitalization is $2.36 Billion with the total Outstanding Shares of 75.01 million. The GEO Group, Inc. (GEO) (“GEO”), a fully integrated equity real estate investment trust (“REIT”) and a leading provider of evidence-based offender rehabilitation and community reentry services around the globe, stated recently its financial results for the third quarter 2016.

Third Quarter 2016 Highlights

Net Income Attributable to GEO of $0.59 per Diluted Share

Net Operating Income of $145.2 million

Normalized FFO of $0.79 per Diluted Share

AFFO of $0.96 per Diluted Share

GEO stated third quarter 2016 net income attributable to GEO of $43.7 million, or $0.59 per diluted share, contrast to $38.3 million, or $0.52 per diluted share, for the third quarter 2015. GEO stated third quarter 2016 Normalized Funds From Operations (“Normalized FFO”) of $59.1 million, or $0.79 per diluted share, contrast to $54.7 million, or $0.74 per diluted share, for the third quarter 2015. GEO stated third quarter 2016 Adjusted Funds From Operations (“AFFO”) of $71.5 million, or $0.96 per diluted share, contrast to $66.3 million, or $0.90 per diluted share, for the third quarter 2015. GEO stated third quarter 2016 Net Operating Income (“NOI”) of $145.2 million contrast to $132.0 million for the third quarter 2015.

Sangamo Biosciences, Inc. (NASDAQ:SGMO), jumped 3.49% and closed at $4.45 in the last trading session. The last trading range of the stock ranges between $4.10 and $4.55.The company stock’s 52-week range is $3.10 – $9.91. Sangamo BioSciences, Inc. (SGMO), the leader in therapeutic genome editing, declared recently that Sandy Macrae, M.B., Ch.B., Ph.D., Sangamo’s president and chief executive officer, will take part in the following conferences in November.

Jefferies 2016 London Healthcare Conference, London, UK, November 16-17, 2016

Dr. Macrae will present an update on the Company’s therapeutic development programs on Thursday, November 17th at 2:00 pm GMT. The presentation will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Shareholder Relations section under Events and Presentation for two weeks after the event.

28th Annual Piper Jaffray Healthcare Conference, New York, NY, November 29-30, 2016

Dr. Macrae will take part in a panel negotiation on Tuesday, November 29th at 3:00 pm ET. Webcasting services are not offered for this session.

Leave a Reply

Your email address will not be published. Required fields are marked *